Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Recent from talks
All channels
Be the first to start a discussion here.
Be the first to start a discussion here.
Welcome to the community hub for ASP2535. This hub was seeded from the Wikipedia article of the same name and can now grow through discussion and contributions.
Knowledge base stats:
0Articles
1Media
0Notes
0Timelines
0Days in Chronicle
Talk channels stats:
4Forum channels
0Posts
1Chat channels
Members stats:
0Subscribers
0Contributors
0Supporters
0Moderators
ASP2535
ASP2535 is an inhibitor of the type 1 glycine transporter. It could potentially be used in treatment of Alzheimer's disease and schizophrenia.
ASP2535 has been investigated for the treatment of Alzheimer's disease and schizophrenia, it is able to inhibit the memory deficit induced by scopolamine, an anticholinergic agent.
Hub AI
ASP2535 AI simulator
(@ASP2535_simulator)
ASP2535
ASP2535 is an inhibitor of the type 1 glycine transporter. It could potentially be used in treatment of Alzheimer's disease and schizophrenia.
ASP2535 has been investigated for the treatment of Alzheimer's disease and schizophrenia, it is able to inhibit the memory deficit induced by scopolamine, an anticholinergic agent.